Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.7K Sell
232
-55
-19% -$6.66K ﹤0.01% 1601
2026
Q1
$46.9K Buy
287
+44
+18% +$6.76K ﹤0.01% 1282
2025
Q4
$42.3K Buy
243
+10
+4% +$1.82K ﹤0.01% 1302
2025
Q3
$33.6K Buy
233
+45
+24% +$5.51K ﹤0.01% 1283
2025
Q2
$18.9K Buy
188
+14
+8% +$1.07K ﹤0.01% 1392
2025
Q1
$13.3K Sell
174
-6
-3% -$459 ﹤0.01% 1448
2024
Q4
$12.4K Hold
180
﹤0.01% 1403
2024
Q3
$13.1K Sell
180
-78
-30% -$5.76K ﹤0.01% 1390
2024
Q2
$17.3K Buy
+258
New +$10K ﹤0.01% 1124

Other funds holding INSM

UMB Bank's INSM Position: Q2 2026 in Review

UMB Bank reduced its Insmed (INSM) stake by 19% in Q2 2026, selling an estimated $6.66K and leaving 232 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

UMB Bank first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $46.9K in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • UMB Bank held 232 shares of Insmed worth $24.7K as of Q2 2026.
  • UMB Bank sold 55 Insmed shares in Q2 2026, an estimated $6.66K.
  • Insmed made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1601 holding.
  • UMB Bank first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • UMB Bank's Insmed position peaked at $46.9K in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.